96 related articles for article (PubMed ID: 4512241)
1. Immunotherapy in well-controlled chronic myelocytic leukemia.
Sokal JE; Aungst CW; Grace JT
N Y State J Med; 1973 May; 73(10):1180-5. PubMed ID: 4512241
[No Abstract] [Full Text] [Related]
2. Immunotherapy of chronic myelocytic leukemia.
Sokal JE; Aungst CW; Grace JT
Natl Cancer Inst Monogr; 1973 Dec; 39():195-8. PubMed ID: 4595316
[No Abstract] [Full Text] [Related]
3. Immunotherapy for chronic granulocytic leukaemia.
Sokal JE
Clin Haematol; 1977 Feb; 6(1):129-39. PubMed ID: 334405
[No Abstract] [Full Text] [Related]
4. Use of Bacillus Calmette-Guérin as adjuvant in human cell vaccines.
Sokal JE; Aungst CW; Han T
Cancer Res; 1972 Jul; 32(7):1584-9. PubMed ID: 4624098
[No Abstract] [Full Text] [Related]
5. Delayed hypersensitivity reactions in patients with acute leukemias and blastic crisis of chronic granulocytic leukemia.
Frydecka I; Becker M
Arch Immunol Ther Exp (Warsz); 1980; 28(4):645-7. PubMed ID: 6935989
[TBL] [Abstract][Full Text] [Related]
6. Impact of specific immunotherapy in acute myelocytic leukemia.
Bekesi JG; Holland JF
Haematol Blood Transfus; 1979; 23():79-87. PubMed ID: 161758
[TBL] [Abstract][Full Text] [Related]
7. [Delayed hypersensitivity reaction and its prognostic significance in patients with myelocytic leukemia].
Turkina AG; Frinovskaia IV; Lobanova NA; Baryshnikov AIu; Mokeeva RA
Gematol Transfuziol; 1987 Jun; 32(6):24-8. PubMed ID: 3476339
[No Abstract] [Full Text] [Related]
8. Failure of immunotherapy to prolong survival in chronic myeloid leukemia.
Jim RT
Hawaii Med J; 1985 Dec; 44(12):471-2. PubMed ID: 3867656
[No Abstract] [Full Text] [Related]
9. [Life expectancy in chronic myelocytic leukemia as dependent upon therapy; Freiburg results from 1947 until 1966].
Musshoff K; Boutis L; Obrecht P; Karsch T
Verh Dtsch Ges Inn Med; 1968; 74():648-52. PubMed ID: 5254017
[No Abstract] [Full Text] [Related]
10. Immunotherapy of acute myeloid leukemia: current approaches.
Smits EL; Berneman ZN; Van Tendeloo VF
Oncologist; 2009 Mar; 14(3):240-52. PubMed ID: 19289488
[TBL] [Abstract][Full Text] [Related]
11. [Studies on humoral and cellular immunity in leukemia and myelofibrosis].
Patakfalvi A; Gógl A; Simon K; Böhm G; Miszlay Z; Kajtsa E
Acta Med Acad Sci Hung; 1970; 27(3):307-19. PubMed ID: 5280019
[No Abstract] [Full Text] [Related]
12. Some observations on the use of chemically labelled normal white blood cells as antigens in active immunization of leukaemia.
Sahasrabudhe MB; Madyastha KR; Prema S; Gollerkeri MP
Biomedicine; 1974 Jan; 20(1):31-9. PubMed ID: 4526246
[No Abstract] [Full Text] [Related]
13. Acute adult myelocytic leukemia: dilemmas in its management.
Duffy TP
Conn Med; 1980 Jul; 44(7):421-3. PubMed ID: 6995006
[No Abstract] [Full Text] [Related]
14. [Chronic myelocytic leukemia. Is the insufficient treatment at the terminal stage a reason for changing therapeutical tactics of the chronic phase?].
Cerný V; Koza I; Hal'ko J; Bohunický L; Krizan Z; Poliaková L; Petrek C; Korec S
Vnitr Lek; 1974 Sep; 20(8):741-5. PubMed ID: 4527291
[No Abstract] [Full Text] [Related]
15. Evaluation of general immune responsiveness in cancer patients.
Joshi CS; Gollerkeri MP; Gangal SG
Indian J Med Res; 1975 Feb; 63(2):315-22. PubMed ID: 1061698
[No Abstract] [Full Text] [Related]
16. Advances in AML immunotherapy: the case for T-bodies.
Suh DY; Frankel AE
Leuk Res; 2007 Feb; 31(2):127-8. PubMed ID: 17137625
[No Abstract] [Full Text] [Related]
17. Chronic idiopathic thrombocytopenic purpura followed by chronic myelocytic leukemia.
Chu JY; Gale GB; O'Connor DM; Bouhasin JD; Gallagher NI
Am J Pediatr Hematol Oncol; 1981; 3(1):83-5. PubMed ID: 6940461
[TBL] [Abstract][Full Text] [Related]
18. [Leukapheresis in chronic myelocytic leukemia].
Shinohara Y; Matsubuchi T; Kawagoe H
Rinsho Ketsueki; 1982 Oct; 23(10):1645-50. PubMed ID: 6961245
[No Abstract] [Full Text] [Related]
19. [Therapeutic cytapheresis in hairy cell leukemia and chronic myelocytic leukemia].
Yoshida Y; Yoshida H; Yamagishi M; Hiraoka A; Uchida M
Rinsho Ketsueki; 1982 Oct; 23(10):1656-60. PubMed ID: 6961246
[No Abstract] [Full Text] [Related]
20. Detailed monitoring of hematopoietic chimerism in a child treated by adoptive immunotherapy for high risk of relapse after BMT for acute myeloid leukemia.
Formánková R; Honzátková L; Sieglová Z; Starý J; Sedlácek P; Brdicka R
Bone Marrow Transplant; 2000 Feb; 25(4):453-6. PubMed ID: 10723591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
